Healio Rheumatology Current Issue

The following articles appeared in the print edition of Healio Rheumatology.
Table of Contents
- Joint Effort: Collaborative Guideline Poised to Confront PsA Challenges
-
- Treatment Guidelines in Rheumatology: What Do You Hear When One Hand Claps? Leonard H. Calabrese, DO
- Multidisciplinary Perspectives in Giant Cell Arteritis: A Team-based Approach for Improved Quality of Care
- Walgreens to Pay $270 Million for Overbilling Prescription Drugs, Insulin Pens
- Belimumab With Standard Care Reduces Organ Damage in Lupus
- Long-term Opioid Use for OA Varies Greatly by State
- Lupus Nephritis Linked to Severe Gut Microbiome Imbalances
- Methotrexate More Effective in Patients With Psoriasis Without PsA
- Nearly 1 in 3 Pre-surgery Patients With OA Use Opioids
-
- Nearly 20% of Patients With Back Pain Report Persistent Symptoms, Greater Health Care Use
- Omalizumab Linked to Improved Disease Activity in SLE
- Only 33% of Patients With Gout Receive Urate-lowering Therapy
- RA Risk Increased up to Fivefold Among Patients With High CCP Levels
- Women With RA Face Reduced Likelihood of Live Birth After Assisted Reproductive Technology
- Taking Their Own Advice: Disparity in Paid Family Leave among Top Medical Schools
- Canadian Rheumatology Association: Medical Cannabis not a Substitute to Standard Care
- DMARDs More Cost Effective, Achieve Similar Outcomes vs. TNF Inhibitors in RA
-
- Majority of Patients With RA Unaware of Risk for Cardiovascular Disease